Product Reimbursement Assistance
Jazz Pharmaceuticals offers support and guidance on reimbursement through our Patient Affairs area to patients and providers for our chronic, patient-administered products, as we understand the challenges you may be facing in obtaining your product and/or insurance coverage. Patient Assistance Programs Jazz Pharmaceuticals currently provides Patient Assistance Programs on Xyrem for U.S. patients who are uninsured and/or underinsured, through the National Organization of Rare Disorders, Inc. (NORD), a non-profit organization dedicated to the identification, treatment and cure of rare ?orphan diseases." Please contact the XYREM success program for more information (1-866-XYREM88). Xyrem? (sodium oxybate) oral solution: Reimbursement assistance is available through the Xyrem Success Program? for registered patients. Please call 1-866-XYREM88 (1-866-997-3688) or visit the www.xyrem.com website for more information.

Our Mission
- Improve patients' lives
- Develop valuable products in psychiatry and neurology
- Always keep patients firmly in mind
Our Inspiration
- Addressing poorly understood conditions and underserved patients
- Improving patient care and developing valuable programs for physicians and patients
News
03/03/2010 | Press ReleaseJazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2009 Financial Results
02/23/2010 | Press Release
Jazz Pharmaceuticals to Announce Fourth Quarter and Full Year 2009 Financial Results on March 3, 2010
02/18/2010 | Press Release
Jazz Pharmaceuticals Announces FDA Acceptance of its New Drug Application for JZP-6 (sodium oxybate) for the Treatment of Fibromyalgia